Want to join the conversation?
$NTAP 1Q16 PR: 2Q16 Outlook: Net revenues are expected to be in the range of $1.40-1.50Bil; GAAP earnings per share is expected to be in the range of $0.35-0.40 per share; Non-GAAP earnings per share is expected to be in the range of $0.55-0.60 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?